Drug Safety Update - October 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for October 2022 (PDF).
This issue advises clinicians that the seventh annual #MedSafetyWeek social media campaign will take place from the 7th to the 13th November 2022. This year the focus is on the importance of reporting suspected adverse reactions to medicines and vaccines. Reports for medical devices or other healthcare products are also encouraged. Healthcare professionals are asked to support the campaign and talk to their patients and colleagues about side effects and how they can report suspected problems to the Yellow Card scheme.
This issue contains the latest COVID-19 vaccine and medicine information including updated shelf life and storage instructions for Spikevax®.
Lastly in this issue is a summary of letters to healthcare professionals in September. These generally related to supply issues and recalls.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « GLP-1 Shortages | NICE Guidance - October 2022 » |
Leave a Comment